Market revenue in 2023 | USD 136.8 million |
Market revenue in 2030 | USD 297.7 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.84% in 2023. Horizon Databook has segmented the France radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Public and private players are entering into partnerships to increase investments, develop infrastructure, and launch new products to ensure sustainable growth. Moreover, rise in incidence of various cancers & cardiovascular diseases, as well as chronic pain is anticipated to fuel market growth.
According to Elsevier B.V., in France, an estimated 110,000 and 230,000 new cases of AF occur each year. Cervical cancer is the fourth most common cancer in women in France. According to HPV Information Centre, annually, 2,862 women are diagnosed with cervical cancer and 1,167 die from the disease.
According to Elsevier B.V., in 2012, 4,615 cases of ovarian cancer were diagnosed in France and 3,140 females died due to the same. Therefore, increasing incidence of cancer is anticipated to raise demand for alternative treatments, such as RFA, instead of chemotherapy or open surgery, in turn propelling the market.
Horizon Databook provides a detailed overview of country-level data and insights on the France radiofrequency ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into France radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account